October 23, 2014 11:51 AM ET

Capital Markets

Company Overview of Novo Nordisk Biotech Fund

Executive Profile

Finn Benned Hansen

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 0 different industries.

See Board Relationships


Mr. Finn Benned Hansen is a Vice President of Business Development and Patents at Novo Nordisk A/s. He is a Director at Novo Nordisk Biotech Fund.

Corporate Headquarters

Novo Alle
Copenhagen, -- 2880


Phone: 45 44 42 49 22
Fax: 45 44 42 18 30

Board Members Memberships



There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novo Nordisk Biotech Fund, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.